Unknown

Dataset Information

0

Mesenchymal stem cell therapy for liver disease: full of chances and challenges.


ABSTRACT: Liver disease is a major health problem that endangers human health worldwide. Currently, whole organ allograft transplantation is the gold standard for the treatment of end-stage liver disease. A shortage of suitable organs, high costs and surgical complications limit the application of liver transplantation. Mesenchymal stem cell therapy has been considered as a promising alternative approach for end-stage liver disease. Some clinical trials have confirmed the effectiveness of MSC therapy for liver disease, but its application has not been promoted and approved. There are still many issues that should be solved prior to using MSC therapy in clinical applications. The types of liver disease that are most suitable for MSC application should be determined, and the preparation and engraftment of MSCs should be standardized. These may be bottlenecks that limit the use of MSCs. We investigated 22 completed and several ongoing clinical trials to discuss these questions from a clinical perspective. We also discussed the important mechanisms by which MSCs play a therapeutic role in liver disease. Finally, we also proposed novel prospective approaches that can improve the therapeutic effect of MSCs.

SUBMITTER: Yang X 

PROVIDER: S-EPMC7590738 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal stem cell therapy for liver disease: full of chances and challenges.

Yang Xue X   Meng Yan Y   Han Zhipeng Z   Ye Fei F   Wei Lixin L   Zong Chen C  

Cell & bioscience 20201027


Liver disease is a major health problem that endangers human health worldwide. Currently, whole organ allograft transplantation is the gold standard for the treatment of end-stage liver disease. A shortage of suitable organs, high costs and surgical complications limit the application of liver transplantation. Mesenchymal stem cell therapy has been considered as a promising alternative approach for end-stage liver disease. Some clinical trials have confirmed the effectiveness of MSC therapy for  ...[more]

Similar Datasets

| S-EPMC6037203 | biostudies-literature
| S-EPMC7641157 | biostudies-literature
| S-EPMC5863358 | biostudies-literature
| S-EPMC3295632 | biostudies-literature
| S-EPMC7347778 | biostudies-literature
| S-EPMC7533900 | biostudies-literature
| S-EPMC8426054 | biostudies-literature
| S-EPMC3086672 | biostudies-literature
| S-EPMC5749272 | biostudies-literature
| S-EPMC7887681 | biostudies-literature